July 18, 2018 NIAID Funding News

Read this full issue online at http://www.niaid.nih.gov/grants-contracts/funding-news-notices

Feature Articles

Connect With Foreign Collaborators Through NIAID’s Bilateral Programs

Bilateral programs are one of many mechanisms NIAID uses to establish research cooperation between Institute-supported U.S. scientists and foreign collaborators.

Opportunities and Resources

NIAID Adds Influenza Vaccine Research to Omnibus Solicitation

NIAID has amended the solicitation to include a research area focused on developing a universal influenza vaccine: Collaborative Influenza Vaccine Innovation Centers (CIVICs).

R01 Opportunity To Study Maternal-Fetal Immune Mechanisms

NIAID seeks research to determine the roles and interactions of immune cells at the maternal-fetal interface that mediate a healthy pregnancy as well as during encounters with infectious agents, vaccinations, or ionizing radiation.

Propose Modeling and Simulation Tools To Improve HIV Prevention Research

Consider applying if you're capable of developing modeling and simulation tools to examine HIV transmission dynamics and estimate the impact of treatment and prevention interventions and strategies.

Pursue Drug-Free Sustained HIV Virologic Remission Using Native or Engineered Monoclonal Antibodies

NIAID seeks to fund research to rapidly assess monoclonal antibodies (mAbs) and move promising mAb candidates through the proof-of-concept stage of clinical development.

In The News

Continuous Submission and Council Deadlines

If you are eligible for continuous submission, you may submit your R01, R21, or R34 application at any time, but NIH will assign it to an Advisory Council round based on a set schedule.

Get Started on Your Loan Repayment Program Application Today

Consider applying to NIH's Loan Repayment Program if you’re an eligible doctoral-level clinician or researcher who’s committed to conducting NIH-qualified research. Should you be awarded, we will repay up to $35,000 each year toward your qualified educational debt.

Expanded Eligibility for G11 Funding Opportunity

An organization that received no more than $8 million in total NIAID grant and cooperative agreement support (direct awards) in the last five years is eligible to apply. Previously, the limit was $2.2 million in total NIH funds.

Advice Corner

A Reminder To Register and Report Clinical Trials

If you have an award to carry out a clinical trial, ensure your research is in good standing by identifying the responsible party, knowing your ClinicalTrials.gov requirements, and creating a system to ensure compliance.